SARCLISA® (isatuximab-irfc) | Site Map

Updated PFS Results Now Available
The latest data for SARCLISA + Kd are ready to view
Kd=carfilzomib and dexamethasone; PFS=progression-free survival.

See updated PFS analysis

MAT-US-2203019-v1.0-04/2022

Kd=carfilzomib and dexamethasone; PFS=progression-free survival.

MAT-US-2203019-v1.0-04/2022

Printed From:

For US Healthcare Professionals Only

Full Prescribing Information Important Safety Information Link to Patient Site

SITE MAP

Home

Efficacy

SARCLISA + Kd (IKEMA)

Trial Design

Trial Results

Subgroup Data

Patient Profiles

SARCLISA + Pd (ICARIA-MM)

Trial Design

Trial Results

Subgroup Data

Patient Profiles

Safety

IKEMA Safety

ICARIA-MM Safety

IRRs/Other Safety Information

Dosing

Mechanism of Action

Access & Resources

CareASSIST Patient Support

Video Resources

Clinical & Access Resources

FAQs

Contact a Rep